BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Los Altos’ AbGenomics Corporation Locks In $16 Million

  October 6, 2014

   · 

  1 min read
• Business

  Ariad Pharmaceuticals, Inc., Bellicum Pharmaceuticals, Inc. Revise Pact; Ariad Will Receive $50 Million In Three Installments

  October 6, 2014

   · 

  4 min read
• Drug Development

  NeoStem, Inc. Announces USAN Approval Of Generic Name ‘Eltrapuldencel-T’ For Investigational Patient-Specific Targeted Cancer Immunotherapy

  October 6, 2014

   · 

  5 min read
• Sun Pharmaceutical Industries Ltd To Invest $280 Million In Experimental Process Of Psoriasis Drug In-Licensed From Merck & Co.

  October 6, 2014

   · 

  1 min read
• Business

  Alliqua Biomedical Announces Expansion To Its Exclusive Licensing Agreement With Celgene Cellular Therapeutics

  October 6, 2014

   · 

  5 min read
• Drug Development

  Alcobra’s ADHD Drug Metadoxine Meets Goals In Late-Stage Study

  October 6, 2014

   · 

  7 min read
• Drug Development

  Foamix Pharmaceuticals, Ltd. Announces Initiation Of Phase 2 Trial With FDX104 In Chemotherapy Induced Rash

  October 6, 2014

   · 

  4 min read
• Lone Star Bio

  Savara Reels In $10 Million

  October 6, 2014

   · 

  3 min read
• Business

  Trinity Biotech To Announce Third Quarter Fiscal 2014 Financial Results

  October 6, 2014

   · 

  2 min read
• Drug Development

  Capricor Therapeutics, Inc. Announces Plans To Pursue Clinical Program For The Treatment Of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs)

  October 6, 2014

   · 

  4 min read